Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

SHA:603567 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	780.96	1,053	1,454	1,001	1,551	1,539
Short-Term Investments	11.03	15.39	14.74	59.45	13.63	-
Trading Asset Securities	0.48	0.54	0.43	0.51	-	-
Cash & Short-Term Investments	792.47	1,069	1,469	1,061	1,565	1,539
Cash Growth	-43.58%	-27.22%	38.43%	-32.17%	1.68%	-39.74%
Accounts Receivable	3,424	3,156	2,525	3,041	3,369	2,654
Other Receivables	1,060	1,085	1,955	811.14	796.85	125.62
Receivables	4,484	4,242	4,480	3,852	4,166	2,779
Inventory	1,694	1,488	720.89	1,006	733.26	959.54
Prepaid Expenses	-	-	19.72	67.58	56.75	0.05
Other Current Assets	381.24	394.08	478.08	394.31	155.07	722.92
Total Current Assets	7,352	7,193	7,168	6,381	6,676	6,001
Property, Plant & Equipment	1,380	1,481	1,426	1,468	1,455	1,460
Long-Term Investments	1,312	1,298	1,266	1,223	1,236	859.65
Goodwill	14.82	14.82	14.82	17.22	18.5	18.5
Other Intangible Assets	981.19	980.37	784.03	764.29	209.36	205.05
Long-Term Deferred Tax Assets	335.81	321.12	302.6	242.28	159.23	149.9
Long-Term Deferred Charges	241.42	246.06	223.03	217.62	167.05	88.21
Other Long-Term Assets	1,252	1,178	1,282	1,364	1,585	1,452
Total Assets	12,868	12,713	12,466	11,678	11,506	10,234
Accounts Payable	265.33	278.16	332.99	806.25	797	581.33
Accrued Expenses	21.14	50.88	43.92	35.76	34.99	100.77
Short-Term Debt	1,276	1,296	876.19	1,302	600.76	500
Current Portion of Long-Term Debt	1,231	439.61	972.69	1,142	1,047	574
Current Portion of Leases	-	4.55	3.8	12.46	3.23	-
Current Income Taxes Payable	129.68	114.16	101.9	190.13	56.84	67.06
Current Unearned Revenue	47.34	55.3	36.46	54.97	12.98	41.04
Other Current Liabilities	226.01	281.61	387.2	323.34	259.28	387.97
Total Current Liabilities	3,196	2,520	2,755	3,867	2,812	2,252
Long-Term Debt	951	1,546	1,298	460	1,290	2,134
Long-Term Leases	9.32	7.97	0.14	9.96	3.53	-
Long-Term Unearned Revenue	149.06	150.11	169.34	181.88	197.24	197.08
Long-Term Deferred Tax Liabilities	37.82	37.91	26.02	5.91	1.37	-
Other Long-Term Liabilities	159.3	159.3	176.57	46.37	150.42	147.92
Total Liabilities	4,502	4,422	4,425	4,571	4,455	4,731
Common Stock	941.14	941.14	941.96	941.96	941.96	849.16
Additional Paid-In Capital	2,339	2,339	2,344	2,350	2,350	1,225
Retained Earnings	4,606	4,531	4,281	3,834	3,749	3,417
Treasury Stock	-15.1	-15.1	-22.04	-29.99	-	-
Comprehensive Income & Other	6.03	4.99	3.93	3.2	2.75	3.62
Total Common Equity	7,877	7,801	7,548	7,099	7,043	5,494
Minority Interest	489.18	490.45	492.27	7.94	8.27	8.69
Shareholders' Equity	8,366	8,291	8,041	7,107	7,051	5,503
Total Liabilities & Equity	12,868	12,713	12,466	11,678	11,506	10,234
Total Debt	3,467	3,294	3,151	2,926	2,945	3,208
Net Cash (Debt)	-2,674	-2,225	-1,682	-1,865	-1,380	-1,669
Net Cash Per Share	-2.84	-2.37	-1.79	-1.98	-1.60	-1.97
Filing Date Shares Outstanding	941.19	941.09	939.4	939.4	941.96	849.16
Total Common Shares Outstanding	941.19	941.09	939.4	939.4	941.96	849.16
Working Capital	4,156	4,673	4,413	2,515	3,864	3,749
Book Value Per Share	8.37	8.29	8.04	7.56	7.48	6.47
Tangible Book Value	6,881	6,805	6,750	6,317	6,815	5,271
Tangible Book Value Per Share	7.31	7.23	7.18	6.72	7.23	6.21
Buildings	-	1,404	1,228	1,232	1,276	1,272
Machinery	-	1,270	1,191	1,139	1,118	1,176
Construction In Progress	-	149.42	284.29	260.83	137.33	66.14

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.